New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
American Society for Radiation Oncology issues updated guideline on radiation therapy for endometrial cancer

American Society for Radiation Oncology issues updated guideline on radiation therapy for endometrial cancer

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainA newly updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations on
Oncology December 28,2023
American Society for Radiation Oncology issues updated guideline on radiation therapy for endometrial cancer

American Society for Radiation Oncology issues updated guideline on radiation therapy for endometrial cancer

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainA newly updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations on
Oncology December 28,2023
American Cancer Society issues nutrition, exercise guidelines for cancer survivors

American Cancer Society issues nutrition, exercise guidelines for cancer survivors

In a guideline issued by the American Cancer Society and published in the May/June issue ofCA: A Cancer Journal for Clinicians, recommendations are presented regarding diet and exercise for redu
Oncology December 28,2023
American Cancer Society issues nutrition, exercise guidelines for cancer survivors

American Cancer Society issues nutrition, exercise guidelines for cancer survivors

In a guideline issued by the American Cancer Society and published in the May/June issue ofCA: A Cancer Journal for Clinicians, recommendations are presented regarding diet and exercise for redu
Oncology December 28,2023
U.S. cancer deaths decline overall, but prostate cancers make rebound

U.S. cancer deaths decline overall, but prostate cancers make rebound

by Dennis ThompsonCancer deaths continue to decline, dropping 33% since 1991 and saving an estimated 3.8 million lives, according to the American Cancer Society's annual statistics report.But indi
Oncology December 28,2023
U.S. cancer deaths decline overall, but prostate cancers make rebound

U.S. cancer deaths decline overall, but prostate cancers make rebound

by Dennis ThompsonCancer deaths continue to decline, dropping 33% since 1991 and saving an estimated 3.8 million lives, according to the American Cancer Society's annual statistics report.But indi
Oncology December 28,2023
Magrolimab plus azacitidine results in promising activity in higher-risk MDS patients

Magrolimab plus azacitidine results in promising activity in higher-risk MDS patients

byH. Lee Moffitt Cancer Center & Research InstituteHemoglobin changes from baseline over time on treatment with magrolimab + azacitidine in patients with HR-MDS (N = 95). Data shown are medi
Oncology December 28,2023
Magrolimab plus azacitidine results in promising activity in higher-risk MDS patients

Magrolimab plus azacitidine results in promising activity in higher-risk MDS patients

byH. Lee Moffitt Cancer Center & Research InstituteHemoglobin changes from baseline over time on treatment with magrolimab + azacitidine in patients with HR-MDS (N = 95). Data shown are medi
Oncology December 28,2023
'No one should cancel their colonoscopies': Addressing controversy from a recent clinical trial

'No one should cancel their colonoscopies': Addressing controversy from a recent clinical trial

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainDespite some confusing messages this week around the value of colonoscopies, Wilmot Cancer Institute physici
Oncology December 28,2023
'No one should cancel their colonoscopies': Addressing controversy from a recent clinical trial

'No one should cancel their colonoscopies': Addressing controversy from a recent clinical trial

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainDespite some confusing messages this week around the value of colonoscopies, Wilmot Cancer Institute physici
Oncology December 28,2023
Adherence to quality indicators low in chronic myeloid leukemia

Adherence to quality indicators low in chronic myeloid leukemia

by Elana Gotkine HealthDay ReporterFor newly diagnosed chronic-phase chronic myeloid leukemia (CML) patients, adherence to guideline-based quality indicators is low, according to a study published onl
Oncology December 28,2023
Adherence to quality indicators low in chronic myeloid leukemia

Adherence to quality indicators low in chronic myeloid leukemia

by Elana Gotkine HealthDay ReporterFor newly diagnosed chronic-phase chronic myeloid leukemia (CML) patients, adherence to guideline-based quality indicators is low, according to a study published onl
Oncology December 28,2023
Chronic health conditions associated with worse survival rates for patients with metastatic breast cancer

Chronic health conditions associated with worse survival rates for patients with metastatic breast cancer

by Mary Clare Fischer, Dani K. Dodge-Medlin,University of MichiganDisparities in the number of chronic health conditions that Black women endure compared to other races and ethnicities contribut
Oncology December 28,2023
Chronic health conditions associated with worse survival rates for patients with metastatic breast cancer

Chronic health conditions associated with worse survival rates for patients with metastatic breast cancer

by Mary Clare Fischer, Dani K. Dodge-Medlin,University of MichiganDisparities in the number of chronic health conditions that Black women endure compared to other races and ethnicities contribut
Oncology December 28,2023
Pulsed electromagnetic field application technique for preventing bone loss due to radiotherapy

Pulsed electromagnetic field application technique for preventing bone loss due to radiotherapy

by Bob Yirka , Medical XpressPEMF ameliorates focal radiation–induced bone loss by modulating osteoblasts. (A) Schematic representation of focal radiation and PEMF administration. (B) Representative m
Oncology December 28,2023
Pulsed electromagnetic field application technique for preventing bone loss due to radiotherapy

Pulsed electromagnetic field application technique for preventing bone loss due to radiotherapy

by Bob Yirka , Medical XpressPEMF ameliorates focal radiation–induced bone loss by modulating osteoblasts. (A) Schematic representation of focal radiation and PEMF administration. (B) Representative m
Oncology December 28,2023
Miami's Little Haiti joins global effort to end cervical cancer

Miami's Little Haiti joins global effort to end cervical cancer

by Verónica ZaragoviaCredit: Unsplash/CC0 Public DomainMore than 300,000 women around the world die from cervical cancer each year. In the U.S., women of Haitian descent are diagnosed with it at highe
Oncology December 28,2023
Miami's Little Haiti joins global effort to end cervical cancer

Miami's Little Haiti joins global effort to end cervical cancer

by Verónica ZaragoviaCredit: Unsplash/CC0 Public DomainMore than 300,000 women around the world die from cervical cancer each year. In the U.S., women of Haitian descent are diagnosed with it at highe
Oncology December 28,2023
Chlorhexidine disinfectant may perform best in killing bone tumor cells after surgery

Chlorhexidine disinfectant may perform best in killing bone tumor cells after surgery

byWolters Kluwer HealthThe widely used disinfectant chlorhexidine gluconate (CHG) appears to be the most effective irrigation solution for use as part of the surgical treatment of bone tumors, s
Oncology December 28,2023
Chlorhexidine disinfectant may perform best in killing bone tumor cells after surgery

Chlorhexidine disinfectant may perform best in killing bone tumor cells after surgery

byWolters Kluwer HealthThe widely used disinfectant chlorhexidine gluconate (CHG) appears to be the most effective irrigation solution for use as part of the surgical treatment of bone tumors, s
Oncology December 28,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com